Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.470
-0.150 (-9.26%)
Jul 28, 2026, 1:50 PM EDT - Market open

Clearmind Medicine Ratios and Metrics

Millions USD. Fiscal year is Nov - Oct.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
2562--
Market Cap Growth
-58.71%-15.15%166.75%---
Enterprise Value
-11.11.22-0.88-3.2900
Last Close Price
1.47318.20556.001464.00--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
PB Ratio
0.144.221.912.26--
P/TBV Ratio
0.013.69----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
EV/EBITDA Ratio
--0.150.53--
EV/EBIT Ratio
--0.150.52--
EV/FCF Ratio
--0.180.52--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Debt / Equity Ratio
0.001.480.01000
Net Debt / Equity Ratio
-1.18-3.19-2.19-5.610.26-0.96
Net Debt / EBITDA Ratio
1.680.681.200.880.051.38
Net Debt / FCF Ratio
2.170.801.400.880.081.77
Quick Ratio
4.731.211.701.160.2213.33
Current Ratio
4.791.221.721.170.2213.78
Return on Equity (ROE)
-124.63%-179.39%-256.89%14071.80%-497.52%-132.38%
Return on Assets (ROA)
-78.75%-86.56%-93.73%-186.33%-251.52%-121.98%
Return on Invested Capital (ROIC)
------3458.44%
Return on Capital Employed (ROCE)
-127.20%-262.58%-279.73%10289.10%-451.09%-130.83%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Buyback Yield / Dilution
-930.62%-----
Total Shareholder Return
-930.62%-----
SEC Filings: 10-K · 10-Q